Diabetes Mellitus (Type 2), Erectile Dysfunction and Diabetic Neuropathy: Georgian Point of View and Experience for Treatment of Such Patients

Z. S. Marshania


Erectile dysfunction (ED) is typically defined as the inability to achieve an erection sufficient for penetration or to maintain an erection following intromission. ED is fairly common problem, affecting as 30 million US men and approximately 5-50% of all men depending on their age group [1].

Full Text:



Rawland D.L. Sexual Dysfunction in Men, Hogrefe Publishing, 2012. P. 107.

Jay D., Sheperd M.D. Evaluation and Treatment of Erectile Dysfunction in Men With Diabetes Mellitus, Mayo Clinic Proceedings March 2002 Volume 77, Issue 3, Pages 276–282

Feldman H.A., Goldstein I., Hatzichristou D.G. et al. Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study // J. Urol. – 1994. – № 151. – P. 54–61.

Fedele D., Coscelli C., Santeusanio F. et al. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici // Diabetes Care. – 1998. – № 21. – P. 1973–77.

International Diabetes Federation. IDF Diabetes Atlas, 6th edn. Brussels, Belgium, 2015. PDF

Fedele et al., Erectile dysfunction in type 1 and type 2 diabetes in Italy. Int J Epidemiol 2000;29:524–31.

International Diabetes Federation. IDF Diabetes Atlas, 6th edn. Brussels, Belgium, 2013. PDF

Diabetic Neuropathies: The Nerve Damage of Diabetes, NIH Publication No. 09-3185, February 2009.

Said G. Peripherial neuropathy & Neuropathy pain – into the light, Guttenberg Press Ltt, 2009, P.197.

Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy // Diab. Care. – 1988. – № 11. – P. 592–597.

Горпинченко И.И. Геронтологическая сексопатология. – Киев. «Здоровья». – 1991. – 167 с.

De Berardis G., Pellegrini F., Franciosi M. et al. Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors // J. Urol. 2003. – № 169. – Р. 1422–1428.

Said G., Diabetic neuropathy. Handb Clin Neurol 2013, 115:579–89.

Vincent A.M. et al. Biology of diabetic neuropathy. Handb Clin Neurol 2013, 115:591–606.

Котов С.П., Калинин А.П., Рудакова И.Г. Диабетическая нейропатия – М. Медицина, 2000.

S Cellek; NE Cameron; MA Cotter; A Muneer. Pathophysiology of Diabetic Erectile Dysfunction Potential Contribution of Vasa Nervorum and Advanced Glycation End Products. Int J Impot Res. 2013;25(1):1–6.

Vinic A., Richardson D. // Diabetes rev. 1998. – Vol. 6 – № 1. – P. 16–33

Erectile Dysfunction in Patients with Diabetes Mellitus Full text

Калинченко С.Ю., Козлов Г.И., Эректильная дисфункция у больных с сахарным диабетом диагностика, дифференциальная диагностика, лечение. – 2003, Full text

Gorpynchenko I.I., Sytenko A.M., The therapeutic concepts for erectile dysfunction: the test of time, Health of Man. – № 3 (58). – 2016. – P. 111–113 PDF

Cameron NE, Cotter MA, Erectile dysfunction and diabetes mellitus: mechanistic considerations from studies in experimental models. Curr Diab Rev 2007;3:149–158.

Chitaley K, Kupelian V, Subak L, Wessels H. Diabetes, obesity and erectile dysfunction: field overview and research priorities. J Urol 2009;182:S45–S50.

Walsh TJ, Hotaling JM, Smith A, Saigal C, Wessels H, Men with Diabetes Require More Aggressive Treatment for Erectile Dysfunction. Int J Impot Res. 2014;26(3):112–115.

Ziegler D. Treatment of Diabetic Polyneuropathy. Update 2006. Ann NY Acad Sci 2006. 1084:250–266.

Kishi et al. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. Diabetes, 1999.48;2045–2051.

Karasu C et al., Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats: comparison with essential acids. Diabetologia 1995.38:129–134.

Dimpfel W., et al., Thioctic Acid induces dose-dependent sprouting of neuritis in cultured rat neuroblastoma cells. Dev Pharmacol Ther 1990.14:193–199.

Zigler et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic neuropathy. Diabetes Care 2006. 29:2365–2370.

Head RA. Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev 2006. 11(4); 294–329.

Kather H., Rittinghausen R., Hatzichristou D.G. et al. Yohimbin: renaissance eines laten medicamentes? // Med. Klin. – 1981. – Bd. 76. – S. 588–589.

Шахраманян В.А. Акопян А.Э. Сексуальные расстройства при сахарном диабете – медицинская наука Армении НАН РА. – № 1. – 2009. – С. 15–30. PDF

Fushimi H. et al., Low testosterone levels in diabetic men and animals: a possible role in testicular impotence. Diabetes Res Clin Pract 1989; 6:297–301

Morales et al. Andropause: a misnomer for a true clinical entity. J Urol 2000; 163:705–12

Basaria S, Dobs AS, Risks versus benefits of testosterone therapy in elderly men. Drugs Aging 1999;15:131–42

Boyanov MA, Boneva Z, Christov VG, Testosteron supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. The Aging Male 2003;6:1–7

Общая сексопатология, руководство для врачей, под ред. Г.С.Васильченко, М. «МЕДИЦИНА», 1977, с. 225–233

Hans Jurgen Eysenck & Sybil B. G. Eysenck (1975). Manual of the Eysenck Personality Questionnaire. London: Hodder and Stough

Rosen RC et al. International Index of Erectile Function(IIEF): A State-of the Science Review. In J Impot Res. 2002;14(4):226–244.

Copyright (c) 2020 Z. S. Marshania

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN 2412-5547 (Online), ISSN 2307-5090 (Print)